What is Fulgent Genetics Inc (FLGT) stock price today?

Fulgent Genetics Inc (FLGT) currently trades at $15.19 per share. The stock has a market capitalization of $470.46M and a P/E ratio of —x.

Is FLGT stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Fulgent Genetics Inc has a Smart Value Score of 44/100 (Grade D), resulting in a "Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is Fulgent Genetics Inc's revenue and earnings?

Fulgent Genetics Inc has trailing twelve-month (TTM) revenue of $322.67M with profit margins of -18.80%. Earnings per share (EPS) is $-1.97.

Is FLGT stock overvalued or undervalued?

Based on our DCF model, Fulgent Genetics Inc's intrinsic value is $65.95, representing a margin of safety of 65.13%. The stock currently trades at a P/E of —x.

FLGT

Fulgent Genetics Inc

NASDAQ: FLGT · HEALTHCARE · DIAGNOSTICS & RESEARCH

$15.19

+2.64% today

Updated 2026-04-30

Market cap

$470.46M

P/E ratio

—

P/S ratio

1.46x

EPS (TTM)

$-1.97

Dividend yield

—

52W range

$13 – $31

Volume

0.7M

Market cap

$470.46M

P/E ratio

—

P/S ratio

1.46x

EPS (TTM)

$-1.97

Dividend yield

—

52W range

$13 – $31

Volume

0.7M

WallStSmart proprietary scores

out of 100

Grade: D

Sell

Investment rating

3.3

Growth

5.0

Quality

C+

2.0

Profitability

7.0

Valuation

B+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →202 stocks currently score above 75

Price targets

Analyst target

$26.00

+71.17%

12-Month target

—

Intrinsic (DCF)

$65.95

Margin of safety

+65.13%

1 Strong Buy1 Buy1 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ 65.13% below intrinsic value

Risks

- Thin margins at -18.80%

- Negative free cash flow $-83.12M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$618.97M	$289.21M	$283.47M	$322.67M	$322.67M
Net income	$143.40M	$-167.82M	$-42.71M	$-60.51M	$-23.42M
EPS	—	—	—	—	$-1.97
Free cash flow	$234.75M	$4.80M	$-19.25M	$-124.21M	$-83.12M
Profit margin	23.17%	-58.03%	-15.07%	-18.75%	-18.80%

Recent insider activity

Date	Insider	Type	Shares	Price
2026-03-09	HSIEH, MING	Sale	750,000	—
2026-03-01	XIE, JIAN	Sale	8,147	$15.33
2026-03-01	XIE, JIAN	Sale	1,079	$15.33

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
FLGT	$470.46M	44	3.3	2.0	7.0	5.0	+65.13%	Hold
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Fulgent Genetics Inc trades at $15.19. Our Smart Value Score of 44/100 indicates the stock is fair. TTM revenue stands at $322.67M. with profit margins at -18.80%. Our DCF model estimates intrinsic value at $65.95.

Frequently asked questions

What is Fulgent Genetics Inc's stock price?

Fulgent Genetics Inc (FLGT) trades at $15.19.

Is Fulgent Genetics Inc overvalued?

Smart Value Score 44/100 (Grade D, Sell). DCF value $65.95.

What is the price target of Fulgent Genetics Inc (FLGT)?

The analyst target price is $26.00, representing +71.2% upside from the current price of $15.19.

What is the intrinsic value of Fulgent Genetics Inc (FLGT)?

Based on our DCF model, intrinsic value is $65.95, a +65.1% margin of safety versus $15.19.

What is Fulgent Genetics Inc's revenue?

TTM revenue is $322.67M.

Company info

SectorHEALTHCARE

IndustryDIAGNOSTICS & RESEARCH

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio1.46x

ROE-5.51%

Beta0.89

50D MA$17.09

200D MA$22.28

Shares out0.03B

Float0.02B

Short ratio—

Avg volume0.7M

Performance

1 week-2.13%

1 month+0.06%

3 months-42.79%

YTD-40.62%

1 year—

3 years—

5 years—

Compare

FLGT vs LLY →FLGT vs JNJ →FLGT vs ABBV →Stock screener →